Legal status · United Kingdom
Is Icotrokinra legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Icotrokinra is not an approved medicine in the United Kingdom; its classification is "Prescription only; check current MHRA status". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Icotrokinra in the United Kingdom at a glance
| Classification | Prescription only; check current MHRA status |
|---|---|
| MHRA approval status | Not approved by MHRA |
| Human studies cited | 2 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Icotrokinra profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
No product containing Icotrokinra is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.
What Icotrokinra is
A 13 amino acid peptide taken as a tablet that blocks the IL-23 receptor. The first oral drug to hit that pathway, in a class that was injection only.
Interleukin-23 drives plaque psoriasis, and the drugs that block it are among the most effective treatments there are. All of them were injected antibodies.
Mechanism: Binds the IL-23 receptor with picomolar affinity and blocks IL-23 signalling. Conventional IL-23 drugs are antibodies that bind the cytokine itself; this binds the receptor, and its small peptide size is what makes oral dosing possible.
Regulatory history: FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only.
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Icotrokinra at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Icotrokinra in other countries
United States
Not approvedPrescription only; FDA approved
Is Icotrokinra legal in the United States?Australia
Not approvedPrescription only; check current TGA status
Is Icotrokinra legal in Australia?Canada
Not approvedPrescription only; check current Health Canada status
Is Icotrokinra legal in Canada?Frequently asked questions
Is Icotrokinra legal in the United Kingdom?
No. Icotrokinra is not an approved medicine in the United Kingdom; its classification is "Prescription only; check current MHRA status". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy Icotrokinra in the United Kingdom?
No approved product exists to buy. In the United Kingdom Icotrokinra is classified as "Prescription only; check current MHRA status", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Icotrokinra MHRA approved?
No. In the United Kingdom Icotrokinra is classified as "Prescription only; check current MHRA status", which is not a MHRA marketing approval. For comparison, the US FDA status is: FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only.. On the evidence, 2 human studies are cited on its profile.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Icotrokinra live on its compound profile.
Icotrokinra profileThis page is general information about the regulatory status of Icotrokinra in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.